Human ULBP-1 PE-conjugated Antibody Summary
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Detection of ULBP‑1 in MOLT‑4 Human Cell Line by Flow Cytometry. MOLT-4 human acute lymphoblastic leukemia cell line was stained with Mouse Anti-Human ULBP-1 PE-conjugated Monoclonal Antibody (Catalog # FAB1380P, filled histogram) or isotype control antibody (Catalog # IC003P, open histogram). View our protocol for Staining Membrane-associated Proteins.
Reconstitution Calculator
Preparation and Storage
Background: ULBP-1
ULBP-1 is a member of a family of cell-surface proteins that function as ligands for human NKG2D. ULBP-1 has also been described under the names RaeT1I (retinoic acid early transcript), ALCAN-beta, and NKG2DL1. The name ULBP-1 derives from the original identification of three proteins, ULBP-1, -2, and -3, as ligands for the human cytomegalovirus glycoprotein UL16; they were designated UL16 binding proteins (ULBP). The gene for ULBP-1 resides in a cluster of ten related genes, six of which encode potentially functional glycoproteins. Amino acid sequence identity within this family ranges from 30-95%. These proteins are distantly related to MHC class I proteins, but they possess only the alpha 1 and alpha 2 Ig-like domains, and they have no capacity to bind peptide or interact with beta 2-microglobulin. They are anchored to the membrane via a GPI-linkage. ULBP-1 and several other family members are known to bind to human NKG2D, an activating receptor expressed on NK cells, NKT cells, gamma δ T cells, and CD8+ alpha beta T cells. Engagement of NKG2D results in the activation of cytolytic activity and/or cytokine production by these effector cells. ULBP-1 is expressed on some tumor cells and has been implicated in tumor surveillance (1-8).
- Cosman, D. et al. (2001) Immunity 14:123.
- Kubin, M. et al. (2001) Eur. J. Immunol. 31:1428.
- Sutherland, C. et al. (2002) J. Immunol. 168:671.
- Steinle, A. et al. (2001) Immunogenetics 53:279.
- Sutherland, C. et al. (2001) Immunol. Rev. 181:185
- Pende, D. et al. (2002) Cancer Res. 62:6178.
- Radosavljevic, M. et al. (2002) Genomics 79:114
- NKG2D and its Ligands, 2002; www.RnDSystems.com.
Product Datasheets
Citations for Human ULBP-1 PE-conjugated Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
25
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Mutual Interaction between Human Multipotent Adult Progenitor Cells and NK Cells
Authors: Sandra A. Jacobs, Jeroen Plessers, Jef Pinxteren, Valerie D. Roobrouck, Catherine M. Verfaillie, Stefaan W. Van Gool
Cell Transplantation
-
Cytoplasmic Citrate Flux Modulates the Immune Stimulatory NKG2D Ligand MICA in Cancer Cells
Authors: Sofie H. Møller, Maiken Mellergaard, Mikkel Madsen, Amaia V. Bermejo, Stine D. Jepsen, Marie H. Hansen et al.
Frontiers in Immunology
-
NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human gamma δ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors
Authors: Guranda Chitadze, Marcus Lettau, Stefanie Luecke, Ting Wang, Ottmar Janssen, Daniel Fürst et al.
OncoImmunology
-
Fumarate Upregulates Surface Expression of ULBP2/ULBP5 by Scavenging Glutathione Antioxidant Capacity
Authors: RI Høgh, A Droujinine, SH Møller, SD Jepsen, M Mellergaar, L Andresen, S Skov
J. Immunol., 2020-03-06;0(0):.
-
CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastoma
Authors: Pascual-Pasto, G;McIntyre, B;Hines, MG;Giudice, AM;Garcia-Gerique, L;Hoffmann, J;Mishra, P;Matlaga, S;Lombardi, S;Shraim, R;Schürch, PM;Yarmarkovich, M;Hofmann, TJ;Alikarami, F;Martinez, D;Tsang, M;Gil-de-Gómez, L;Spear, TT;Bernt, KM;Wolpaw, AJ;Dimitrov, DS;Li, W;Bosse, KR;
Nature communications
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma
Authors: Jones, AB;Tuy, K;Hawkins, CC;Quinn, CH;Saad, J;Gary, SE;Beierle, EA;Ding, L;Rochlin, KM;Lamb, LS;Hjelmeland, AB;
Cancers
Species: Xenograft
Sample Types: Whole Cells
Applications: Flow Cytometry -
XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression
Authors: Fisher, JG;Doyle, ADP;Graham, LV;Sonar, S;Sale, B;Henderson, I;Del Rio, L;Johnson, PWM;Landesman, Y;Cragg, MS;Forconi, F;Walker, CJ;Khakoo, SI;Blunt, MD;
Leukemia
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Antitumor effects of NK cells expanded by activation pre?processing of autologous feeder cells before irradiation in colorectal cancer
Authors: Koh, EK;Lee, HR;Son, WC;Park, GY;Bae, J;Park, YS;
Oncology letters
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
gammadelta T cells are effectors of immunotherapy in cancers with HLA class I defects
Authors: NL de Vries, J van de Haa, V Veninga, M Chalabi, ME Ijsselstei, M van der Pl, J van den Bu, D Ruano, JG van den Be, JB Haanen, LJ Zeverijn, BS Geurts, GF de Wit, TW Battaglia, H Gelderblom, HMW Verheul, TN Schumacher, LFA Wessels, F Koning, NFCC de Miranda, EE Voest
Nature, 2023-01-11;613(7945):743-750.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcoma
Authors: Y Murayama, Y Kasahara, N Kubo, C Shin, M Imamura, N Oike, T Ariizumi, A Saitoh, M Baba, T Miyazaki, Y Suzuki, Y Ling, S Okuda, K Mihara, A Ogose, H Kawashima, C Imai
Translational Oncology, 2022-08-20;25(0):101521.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Venetoclax enhances NK cell killing sensitivity of AML cells through the NKG2D/NKG2DL activation pathway
Authors: HY Wu, KX Li, WY Pan, MQ Guo, DZ Qiu, YJ He, YH Li, YX Huang
International immunopharmacology, 2022-01-06;104(0):108497.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway
Authors: T Seki, Y Shimizu, K Ishii, Y Takahama, K Kato, T Yano
Biomolecules, 2021-11-16;11(11):.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Bufalin enhances the killing efficacy of NK cells against hepatocellular carcinoma by inhibiting MICA shedding
Authors: R Fu, F Yu, W Wu, J Liu, J Li, F Guo, L Xu, F Wang, X Cui
International immunopharmacology, 2021-10-19;101(0):108195.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Expression of NK Cell Receptor Ligands on Leukemic Cells Is Associated with the Outcome of Childhood Acute Leukemia
Authors: MV Martínez-S, JL Fuster, JA Campillo, AM Galera, M Bermúdez-C, ME Llinares, E Ramos-Elba, JF Pascual-Gá, AM Fita, H Martínez-B, JA Galián, L Gimeno, M Muro, A Minguela
Cancers, 2021-05-11;13(10):.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Chemotherapy agents stimulate dendritic cells against human colon cancer cells through upregulation of the transporter associated with antigen processing
Authors: YH Liang, JH Tsai, YM Cheng, KY Chan, WL Hsu, CC Lee, KH Chen, KH Yeh
Scientific Reports, 2021-04-27;11(1):9080.
Species: Human
Sample Types: Cell Lysates, Whole Cells
Applications: Flow Cytometry, Western Blot -
iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity
Authors: D Suzuki, C Flahou, N Yoshikawa, I Stirblyte, Y Hayashi, A Sawaguchi, M Akasaka, S Nakamura, N Higashi, H Xu, T Matsumoto, K Fujio, MG Manz, A Hotta, H Takizawa, K Eto, N Sugimoto
Stem Cell Reports, 2019-12-26;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy
Authors: M Chollat-Na, T Ben Safta-, D Haferssas, G Meurice, S Chouaib, J Thiery
Cell Death Dis, 2019-09-20;10(10):695.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Control of triple-negative breast cancer using ex vivo self-enriched, costimulated NKG2D CAR T cells
Authors: Y Han, W Xie, DG Song, DJ Powell
J Hematol Oncol, 2018-07-06;11(1):92.
Species: Human
Sample Types: Whole Cells
Applications: CAR-T (Flow Cytometry) -
Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells
Authors: JRM Van Audena, J De Waele, E Marcq, J Van Loenho, E Lion, JMJ Van den Be, R Jesenofsky, A Masamune, G Roeyen, P Pauwels, F Lardon, M Peeters, ELJ Smits
Oncotarget, 2017-01-01;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function
PLoS Pathog, 2016-08-16;12(8):e1005782.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts
Blood, 2016-03-24;127(23):2879-89.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia.
Authors: Parrish C, Scott G, Migneco G, Scott K, Steele L, Ilett E, West E, Hall K, Selby P, Buchanan D, Varghese A, Cragg M, Coffey M, Hillmen P, Melcher A, Errington-Mais F
Leukemia, 2015-03-27;29(9):1799-810.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Natural killer cell-mediated shedding of ULBP2.
Authors: Wang, Ruipeng, Sun, Peter D
PLoS ONE, 2014-03-10;9(3):e91133.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Expression levels of UL16 binding protein 1 and natural killer group 2 member D affect overall survival in patients with gastric cancer following gastrectomy
Authors: Ryoji Kamei, Kiyoshi Yoshimura, Shigefumi Yoshino, Moeko Inoue, Tetsuhiko Asao, Masanori Fuse et al.
Oncology Letters
-
NKG2D discriminates diverse ligands through selectively mechano‐regulated ligand conformational changes
Authors: Juan Fan, Jiawei Shi, Yong Zhang, Junwei Liu, Chenyi An, Huaying Zhu et al.
The EMBO Journal
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human ULBP-1 PE-conjugated Antibody
There are currently no reviews for this product. Be the first to review Human ULBP-1 PE-conjugated Antibody and earn rewards!
Have you used Human ULBP-1 PE-conjugated Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image